NCT00507949View on ClinicalTrials.gov

Study to Evaluate the Effect of Megestrol Acetate in Severe Chronic Obstructive Pulmonary Disease With Loss of Weight

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

April 30, 2009

Study Completion Date

September 30, 2009

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

Megestrol acetate

Sachets of 160 mg of granulated. Dosage 160 mg /b.i.d. Duration 8 weeks.

DRUG

placebo

sachets of granulate of 160 mg. Dosage 160 mg b.i.d. Duration 8 weeks.

Trial Locations (1)

46017

Neumology Service of the Hospital Universitario Dr. Peset, Valencia

All Listed Sponsors
lead

Rottapharm Spain

INDUSTRY

NCT00507949 - Study to Evaluate the Effect of Megestrol Acetate in Severe Chronic Obstructive Pulmonary Disease With Loss of Weight | Biotech Hunter | Biotech Hunter